Clinical Trial Update: Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on the efficacy and safety of paclitaxel liposome plus S-1 as first-line therapy for advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Paclitaxel liposome (liposomal paclitaxel)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Fudan University | Conditions: Advanced Pancreatic Cancer | Phase 4 | Status: UNKNOWN